BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23660119)

  • 1. Beta-blocker use and clinical outcomes after primary vascular surgery: a nationwide propensity score-matched study.
    Høgh A; Lindholt JS; Nielsen H; Jensen LP; Johnsen SP
    Eur J Vasc Endovasc Surg; 2013 Jul; 46(1):93-102. PubMed ID: 23660119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of angiotensin-converting enzyme inhibitors and cardiovascular outcomes following primary vascular surgery: a nationwide propensity score matched follow-up study.
    Høgh A; Lindholt JS; Nielsen H; Jensen LP; Johnsen SP
    Vasc Endovascular Surg; 2012 Oct; 46(7):515-23. PubMed ID: 22843293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
    Høgh AL
    Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study.
    Andersson C; Mérie C; Jørgensen M; Gislason GH; Torp-Pedersen C; Overgaard C; Køber L; Jensen PF; Hlatky MA
    JAMA Intern Med; 2014 Mar; 174(3):336-44. PubMed ID: 24247428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase of 1-year mortality after perioperative beta-blocker withdrawal in endovascular and vascular surgery patients.
    Hoeks SE; Scholte Op Reimer WJ; van Urk H; Jörning PJ; Boersma E; Simoons ML; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2007 Jan; 33(1):13-9. PubMed ID: 16935011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary medical prevention after primary vascular surgery between 1996 and 2006: a shift towards more evidence-based treatment.
    Høgh A; Lindholt JS; Nielsen H; Jensen LP; Johnsen SP
    Eur J Prev Cardiol; 2013 Oct; 20(5):763-70. PubMed ID: 22637739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.
    Bangalore S; Steg G; Deedwania P; Crowley K; Eagle KA; Goto S; Ohman EM; Cannon CP; Smith SC; Zeymer U; Hoffman EB; Messerli FH; Bhatt DL;
    JAMA; 2012 Oct; 308(13):1340-9. PubMed ID: 23032550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-blockers and cardiovascular events in patients with and without myocardial infarction: post hoc analysis from the CHARISMA trial.
    Bangalore S; Bhatt DL; Steg PG; Weber MA; Boden WE; Hamm CW; Montalescot G; Hsu A; Fox KA; Lincoff AM
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):872-81. PubMed ID: 25271049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of preoperative statin therapy on cardiovascular outcomes in patients undergoing infrainguinal vascular surgery.
    Ward RP; Leeper NJ; Kirkpatrick JN; Lang RM; Sorrentino MJ; Williams KA
    Int J Cardiol; 2005 Oct; 104(3):264-8. PubMed ID: 16186054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use and adherence to beta-blockers for secondary prevention of myocardial infarction: who is not getting the treatment?
    Wei L; Flynn R; Murray GD; MacDonald TM
    Pharmacoepidemiol Drug Saf; 2004 Nov; 13(11):761-6. PubMed ID: 15386713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of post-operative clopidogrel treatment in patients revascularized with coronary artery bypass grafting after myocardial infarction.
    Sørensen R; Abildstrøm SZ; Hansen PR; Hvelplund A; Andersson C; Charlot M; Fosbøl EL; Køber L; Madsen JK; Gislason GH; Torp-Pedersen C
    J Am Coll Cardiol; 2011 Mar; 57(10):1202-9. PubMed ID: 21371637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta1- and beta2-adrenergic receptor gene variation, beta-blocker use and risk of myocardial infarction and stroke.
    Lemaitre RN; Heckbert SR; Sotoodehnia N; Bis JC; Smith NL; Marciante KD; Hindorff LA; Lange LA; Lumley TS; Rice KM; Wiggins KL; Psaty BM
    Am J Hypertens; 2008 Mar; 21(3):290-6. PubMed ID: 18219297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Blocker-Associated Risks in Patients With Uncomplicated Hypertension Undergoing Noncardiac Surgery.
    Jørgensen ME; Hlatky MA; Køber L; Sanders RD; Torp-Pedersen C; Gislason GH; Jensen PF; Andersson C
    JAMA Intern Med; 2015 Dec; 175(12):1923-31. PubMed ID: 26436291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Male Sex Associated with Increased Long-term Cardiovascular Mortality after Peripheral Vascular Surgery for Atherosclerosis Despite Optimal Medical Treatment.
    Budtz-Lilly JW; Petersen CN; Pedersen TF; Eldrup N
    Eur J Vasc Endovasc Surg; 2015 Dec; 50(6):767-73. PubMed ID: 26371415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-blocker in post-myocardial infarct survivors with preserved left ventricular systolic function.
    Siu CW; Pong V; Jim MH; Yue WS; Ho HH; Li SW; Lau CP; Tse HF
    Pacing Clin Electrophysiol; 2010 Jun; 33(6):675-80. PubMed ID: 20132502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of beta-blocker prescription on the incidence of postoperative myocardial infarction after hip and knee arthroplasty.
    van Klei WA; Bryson GL; Yang H; Forster AJ
    Anesthesiology; 2009 Oct; 111(4):717-24. PubMed ID: 19707119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of postoperative nadir hemoglobin and blood transfusion on outcomes after operations for atherosclerotic vascular disease.
    Kougias P; Orcutt S; Pak T; Pisimisis G; Barshes NR; Lin PH; Bechara CF
    J Vasc Surg; 2013 May; 57(5):1331-7; discussion. PubMed ID: 23384496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex-related differences in outcome after high-risk vascular surgery after the administration of beta-adrenergic-blocking drugs.
    Matyal R; Mahmood F; Panzica P; Pomposelli F; Park KW; Hamden A; Schermerhorn M; Hess P
    J Cardiothorac Vasc Anesth; 2008 Jun; 22(3):354-60. PubMed ID: 18503921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-blocker therapy is not associated with adverse outcomes in patients with pulmonary arterial hypertension: a propensity score analysis.
    Thenappan T; Roy SS; Duval S; Glassner-Kolmin C; Gomberg-Maitland M
    Circ Heart Fail; 2014 Nov; 7(6):903-10. PubMed ID: 25277998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk-adjusted 30-day outcomes of carotid stenting and endarterectomy: results from the SVS Vascular Registry.
    Sidawy AN; Zwolak RM; White RA; Siami FS; Schermerhorn ML; Sicard GA;
    J Vasc Surg; 2009 Jan; 49(1):71-9. PubMed ID: 19028045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.